Lapam Capital Leads Antibody-Drug Conjugates
21 Nov 2025
US$ 20.00
Lapam Capital has led the US$60 m pre-series A+ financing round of Phrontline Biopharma (Phrontline), joined by Samsung...
Related Publications
Subscribers’ Weekly ending 22 May 2026...
Once largely discreet and illusive in the private capital markets outside of their domains, they are now among the ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.